Piramal Pharma Limited

Piramal Pharma Limited

Piramal Pharma Limited received a query from the Stock Exchanges regarding a news article about a 10% surge in its share price. The company clarified that the news article does not contain any material information requiring disclosure under Regulation 30 of SEBI Listing Regulations. It further stated that all necessary information is already in the public domain and that the share price movement appears to be driven by market dynamics, with no specific undisclosed reason known to the company.

Piramal Pharma Limited

The National Stock Exchange (NSE) has formally requested Piramal Pharma Limited to provide clarification regarding a recent news article titled 'Piramal Pharma Share Price Spikes Over 10% - What Is Driving The Rally?'. The company's official response to this inquiry is still pending. This request is a standard compliance procedure aimed at ensuring market transparency and verifying the information contributing to significant stock price movements.

Piramal Pharma Limited

Piramal Pharma Limited announced the publication of newspaper advertisements informing shareholders about its upcoming 6th Annual General Meeting (AGM). The AGM is scheduled for Thursday, July 30, 2026, at 3:00 p.m. (IST) and will be conducted virtually via Video Conferencing or Other Audio Visual Means. Notices were published in Business Standard (English) and Mumbai Lakshadweep (Marathi), in compliance with SEBI Listing Regulations. This announcement formally notifies investors about the meeting where key company matters will be discussed, enabling them to prepare for participation.